Can I Take Melatonin with Accutane (Isotretinoin)?

The direct answer

The current Absorica/Absorica LD label does not identify melatonin as a drug interaction. [1] This does not establish that every sleep blend, dose or additional medication has been studied with isotretinoin. It does mean a specific interaction should not be invented solely because both substances are processed by the liver.

If you are already taking both, give your dermatologist the melatonin brand, formulation, milligrams per serving, amount actually taken and how often you use it. Note when sleep problems began relative to isotretinoin initiation or dose changes.

A useful answer should distinguish three questions: whether the two products interact, whether melatonin is helping the sleep problem, and whether the sleep change itself needs assessment. Those are separate decisions.

Check the isotretinoin formulation before changing meals or timing

Some isotretinoin products have food-dependent instructions. Absorica and Absorica LD are specifically labeled for administration without regard to meals, and they have different bioavailability and recommended doses. [1] Follow the directions on the dispensed product rather than assuming every capsule requires a high-fat dinner.

Likewise, taking melatonin later in the evening does not create a proven protective gap from isotretinoin. A bedtime schedule should serve the sleep treatment, not an unsupported interaction rule.

For melatonin, immediate-release and prolonged-release products are not interchangeable in purpose or timing. For example, prescription Circadin is a 2 mg prolonged-release product with instructions to take it one to two hours before bedtime after food, for its labeled population aged 55 and older. [2] That schedule cannot simply be assigned to every US supplement or to an adolescent taking acne treatment.

A real interaction to recognize: fluvoxamine and melatonin

In a human pharmacokinetic study, five healthy men received melatonin 5 mg with or without fluvoxamine 50 mg. Fluvoxamine increased average melatonin exposure approximately 17-fold and peak concentration approximately 12-fold. [3]

This was a melatonin-fluvoxamine study, not an isotretinoin study. It also shows why the issue is not confined to unusually large melatonin doses. The Circadin prescribing information advises avoiding the fluvoxamine combination. [2]

If fluvoxamine appears on the medicine list, discuss the melatonin specifically with the prescriber or pharmacist. Separating it from isotretinoin does not address that interaction. Caffeine use is also worth recording when evaluating sleep, but caffeine and fluvoxamine should not be presented as equivalent exposures with the same measured effect.

Melatonin gummies: check the amount you are actually taking

A 2023 laboratory analysis tested 25 US melatonin gummy products. Twenty-two did not meet the study's labeling-accuracy criterion. Among products containing melatonin, measured amounts ranged from 74% to 347% of the labeled quantity; one product contained no detectable melatonin. [4]

This finding does not describe every current brand or batch. It explains why unexplained morning grogginess warrants a product review as well as a dose review. Confirm whether the label gives milligrams per gummy or per serving and whether the serving contains more than one gummy. Record other ingredients in a sleep blend rather than treating the entire product as melatonin alone.

In the United States, melatonin is regulated as a dietary supplement. That is different from calling it unregulated, and it is also different from the review process for a prescription sleep medicine. [5]

Liver tests, triglycerides and glucose

Isotretinoin's existing monitoring plan applies whether or not melatonin is used. Current prescribing information calls for lipid and liver assessment before treatment and follow-up during treatment. Existing pregnancy-related treatment requirements also remain part of the isotretinoin plan. [1]

A 2022 international Delphi study of 22 acne experts supported checking ALT and triglycerides before treatment and at peak dose, rather than routine monthly testing for everyone. It did not support routine complete blood counts or basic metabolic panels in otherwise routine isotretinoin monitoring. [6] Your clinician can adjust the plan for abnormal baseline results, symptoms or relevant medical conditions.

Glucose is a separate question. In a placebo-controlled study of 21 healthy women, 5 mg melatonin taken 15 minutes before a glucose-tolerance test impaired the glucose response in both morning and evening testing. [7] This was an acute laboratory experiment. It was not a study of isotretinoin users, did not establish new diabetes from the combination and cannot define an extra testing schedule for everyone who takes both.

For someone with diabetes, abnormal glucose results or symptoms such as excessive thirst and frequent urination, the existing metabolic history provides a reason for individualized assessment. A theoretical interaction alone does not justify automatically adding repeated blood tests.

Address the sleep problem itself

New insomnia, a changed sleep schedule and next-day sedation are different problems. A brief sleep record can help distinguish them: bedtime, estimated time to sleep, awakenings, wake time, melatonin timing and next-day function.

For chronic insomnia in adults, the American Academy of Sleep Medicine recommends multicomponent cognitive behavioral therapy for insomnia, or CBT-I. It also recommends against using sleep-hygiene advice as the sole treatment. [8] CBT-I addresses sleep timing, learned wakefulness and thoughts that perpetuate insomnia; it is more than a reminder to put a phone away.

This distinction matters if a supplement is repeatedly being increased without a clear benefit. The treatment should match the sleep disorder. An adolescent's plan should be assessed with the treating clinician and parent or caregiver rather than copied from adult supplement advice. [5]

What if you want to stop melatonin?

Melatonin should not be described as inevitably causing rebound insomnia when stopped. Studies summarized in the Circadin label found no withdrawal symptoms or rebound insomnia after treatment in the populations tested. [2] That does not establish identical results for every high-dose supplement, but it corrects the idea that everyone must continue it to avoid withdrawal.

If sleep worsens after stopping, review whether the original sleep problem remains, whether timing changed and whether the product contained other active ingredients. A persistent problem deserves a sleep assessment rather than an assumption of dependence.

Symptoms to bring to your dermatologist

Report ongoing sleep disruption, mood changes or morning grogginess that interferes with normal function. A new severe headache with visual changes needs prompt assessment during isotretinoin treatment. Dark urine, significant upper-abdominal pain or marked new thirst and urination should also be evaluated rather than attributed automatically to a sleep supplement.

Do not use a general instruction to continue both products regardless of symptoms. The appropriate response depends on what changed and the advice for the actual medicine being taken.

References